Abstract
We appreciate the comments shared by Wang and colleagues.1Here we provide responses to the key comments that were raised and highlight relevant aspects in our original publication2and from our research.The first point highlighted by Wang et al was regarding the limitations associated with using diagnosis codes for the identification of rheumatoid arthritis (RA) and herpes zoster (HZ) cases.1
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology